Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE American - Delayed Quote USD

Myomo, Inc. (MYO)

Compare
4.2700
-0.2100
(-4.69%)
At close: 4:00:00 PM EDT
4.2501
-0.04
(-0.93%)
After hours: 4:09:08 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Paul R. Gudonis Chairman, President & CEO 526.56k -- 1955
Mr. David A. Henry Chief Financial Officer 401.56k -- 1961
Dr. Harry Kovelman M.D. Chief Medical Officer 426.03k -- 1959
Mr. Colin Anderson Global Director of Operations -- -- --
Mr. Joseph Chicoskie Director of Marketing -- -- --
Ms. Galina Shtivelman Senior Director of Human Resources -- -- --
Mr. Micah J. Mitchell Chief Commercial Officer 317.39k -- 1976

Myomo, Inc.

45 Blue Sky Dr.
Suite 101
Burlington, MA 01803
United States
617 996 9058 https://myomo.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
184

Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. It sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Corporate Governance

Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 6, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

Myomo, Inc. Earnings Date

Recent Events

April 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 10, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 20, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 6, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 26, 2024 at 12:00 AM UTC

S-3/A: Offering Registrations

August 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 6, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers